missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Invitrogen™ Brevican Polyclonal Antibody
Rabbit Polyclonal Antibody
Brand: Invitrogen™ PA525808
Denne vare kan ikke returneres.
Se returpolitik
Beskrivelse
This antibody is predicted to react with bovine based on sequence homology.
Brevican is the most abundant chondroitin sulfate proteoglycan in the extracellular matrix of the adult brain. It is a member of the lectican family of aggregating extracellular matrix proteoglycans that bear chondroitin sulfate (CS) chains. It is highly expressed in the central nervous system and is thought to stabilize synapses and inhibit neural plasticity. Brevican is secreted from astrocytes and neurons as a 145 kD core protein that bears up to three, covalently-linked, CS chains. It is also is secreted as a 145 kD core protein without CS chains. When cleaved by extracellular glutamyl endopeptidases, the ADAMTSs, a 55 kD N-terminal fragment is formed that contains the unique C terminal epitope EAMESE.
Tekniske data
| Brevican | |
| Polyclonal | |
| Unconjugated | |
| Bcan | |
| ALPBRE; Bcan; Behab; Brain-enriched hyaluronan-binding protein; brevican; brevican (brain specific proteoglycan in the aggrecan family); brevican core protein; Chondroitin sulfate proteoglycan 7; chondroitin sulfate proteoglycan BEHAB; CSPG7; UNQ2525/PRO6018 | |
| Rabbit | |
| Antigen Affinity Chromatography, Protein A | |
| RUO | |
| 63827 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Flow Cytometry, Immunohistochemistry (Paraffin), Western Blot | |
| 0.34 mg/mL | |
| PBS with 0.09% sodium azide; pH 7.4 | |
| Q96GW7 | |
| Bcan | |
| KLH conjugated synthetic peptide between 715-741 amino acids from the C-terminal region of human BCAN. | |
| 400 μL | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
Korrektion af produktindhold
Dit input er vigtigt for os. Udfyld denne formular for at give feedback relateret til indholdet på dette produkt.
Produkttitel
Ser du en mulighed for forbedring?Del en indholdskorrektion